title: Promotion of colorectal neoplasia in experimental murine ulcerative colitis.
abstract: BACKGROUND
  The mechanisms underlying the frequent development of colorectal carcinomas in patients with ulcerative colitis are still unknown.
  
  
  OBJECTIVE
  To evaluate whether mucosal necrosis and regeneration act as enhancing or promoting factors in colorectal tumorigenesis, development of multiple colorectal tumours was studied in a murine model of ulcerative colitis with azoxymethane pretreatment.
  
  
  METHODS
  Periods of chronic ulcerative colitis in mice were induced by three repeated administrations of 3% dextran sulphate sodium subsequent to a single azoxymethane pretreatment, to give conditions similar to the clinically observed active and remission phases.
  
  
  RESULTS
  In the chronic colitis group with carcinogen exposure, multiple mucosal tumours (10.5/mouse) developed in the colorectum. This occurred primarily on the left side of the large intestine or transverse colon, the sites of the most severe colitic injury. The observed lesions were high grade dysplasias and invasive adenocarcinomas. Increased cell proliferation was evidenced by high uptake of bromodeoxyuridine, and increased activities of thymidylate synthetase and thymidine kinase. No tumours were induced in the control groups with azoxymethane pretreatment or chronic colitis alone.
  
  
  CONCLUSIONS
  Repeated mucosal erosion with necrosis and regeneration is critical for the development of colorectal tumours in this experimental colitis system.
authors.affiliation: Department of Pathology, Kitasato University, Kanagawa, Japan.
authors.forename: I
authors.initials: I
authors.lastname: Okayasu
authors.forename: T
authors.initials: T
authors.lastname: Ohkusa
authors.forename: K
authors.initials: K
authors.lastname: Kajiura
authors.forename: J
authors.initials: J
authors.lastname: Kanno
authors.forename: S
authors.initials: S
authors.lastname: Sakamoto
mesh_terms: D000818:Animals; D001397:Azoxymethane / Q000008:administration & dosage; D002273:Carcinogens / Q000008:administration & dosage; D002908:Chronic Disease; D003093:Colitis, Ulcerative / Q000150:complications* / Q000201:enzymology; D003106:Colon / Q000473:pathology; D015179:Colorectal Neoplasms / Q000209:etiology*; D016264:Dextran Sulfate / Q000008:administration & dosage; D005260:Female; D007413:Intestinal Mucosa / Q000473:pathology; D051379:Mice; D008808:Mice, Inbred CBA; D009336:Necrosis; D013937:Thymidine Kinase / Q000032:analysis; D013940:Thymidylate Synthase / Q000032:analysis
chemical_list: D002273:Carcinogens; D016264:Dextran Sulfate; D013940:Thymidylate Synthase; D013937:Thymidine Kinase; D001397:Azoxymethane